Takeda Pharmaceutical Co Ltd ADR (TAK) — Cash Flow Quality Index
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Cash Flow Quality Index of 3.41x as of December 2025. Operating cash flow of $360.04 Billion exceeds net income of $105.51 Billion, indicating high earnings quality where cash backs reported profits. Explore TAK cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Takeda Pharmaceutical Co Ltd ADR Cash Flow Quality Index (2000–2025)
Historical Cash Flow Quality Index for Takeda Pharmaceutical Co Ltd ADR across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check TAK capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Takeda Pharmaceutical Co Ltd ADR (2000–2025)
Year-by-year earnings quality comparison for Takeda Pharmaceutical Co Ltd ADR. For live market cap and the full company financial profile, see market cap of Takeda Pharmaceutical Co Ltd ADR.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 9.80x | $1.06 Trillion | $107.93 Billion | ▲ +97.0% |
| 2024 | 4.97x | $716.34 Billion | $144.07 Billion | ▲ +61.3% |
| 2023 | 3.08x | $977.16 Billion | $317.04 Billion | ▼ -36.8% |
| 2022 | 4.88x | $1.12 Trillion | $230.17 Billion | ▲ +81.6% |
| 2021 | 2.69x | $1.01 Trillion | $376.17 Billion | ▼ -82.2% |
| 2020 | 15.12x | $669.75 Billion | $44.29 Billion | ▲ +401.9% |
| 2019 | 3.01x | $328.48 Billion | $109.01 Billion | ▲ +48.9% |
| 2018 | 2.02x | $377.85 Billion | $186.71 Billion | ▼ -10.6% |
| 2017 | 2.26x | $261.36 Billion | $115.51 Billion | ▲ +641.0% |
| 2016 | 0.31x | $25.49 Billion | $83.48 Billion | ▼ -77.4% |
| 2014 | 1.35x | $148.34 Billion | $109.56 Billion | ▼ -42.9% |
| 2013 | 2.37x | $307.71 Billion | $129.71 Billion | ▲ +78.0% |
| 2012 | 1.33x | $336.57 Billion | $252.48 Billion | ▲ +51.5% |
| 2011 | 0.88x | $326.94 Billion | $371.57 Billion | ▼ -4.0% |
| 2010 | 0.92x | $381.17 Billion | $415.83 Billion | ▲ +12.0% |
| 2009 | 0.82x | $326.27 Billion | $398.55 Billion | ▲ +61.5% |
| 2008 | 0.51x | $292.50 Billion | $576.84 Billion | ▲ +51.5% |
| 2007 | 0.33x | $209.28 Billion | $625.38 Billion | ▼ -53.6% |
| 2006 | 0.72x | $373.57 Billion | $517.96 Billion | ▲ +7.6% |
| 2005 | 0.67x | $295.54 Billion | $441.10 Billion | ▼ -3.9% |
| 2004 | 0.70x | $311.12 Billion | $446.14 Billion | ▲ +14.3% |
| 2003 | 0.61x | $263.45 Billion | $431.90 Billion | ▼ -40.3% |
| 2002 | 1.02x | $240.59 Billion | $235.66 Billion | ▲ +26.3% |
| 2001 | 0.81x | $212.66 Billion | $263.08 Billion | ▼ -39.2% |
| 2000 | 1.33x | $158.96 Billion | $119.62 Billion | — |